- Home
- PED vs TPST Comparison
PED vs TPST Comparison
Compare PED & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PED
- TPST
- Stock Information
- Founded
- PED N/A
- TPST 2011
- Country
- PED United States
- TPST United States
- Employees
- PED N/A
- TPST N/A
- Industry
- PED Oil & Gas Production
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- PED Energy
- TPST Health Care
- Exchange
- PED Nasdaq
- TPST Nasdaq
- Market Cap
- PED 52.8M
- TPST 45.5M
- IPO Year
- PED N/A
- TPST N/A
- Fundamental
- Price
- PED $0.59
- TPST $10.52
- Analyst Decision
- PED Strong Buy
- TPST Hold
- Analyst Count
- PED 1
- TPST 3
- Target Price
- PED $1.50
- TPST $30.00
- AVG Volume (30 Days)
- PED 223.2K
- TPST 43.7K
- Earning Date
- PED 11-12-2025
- TPST 11-07-2025
- Dividend Yield
- PED N/A
- TPST N/A
- EPS Growth
- PED 569.41
- TPST N/A
- EPS
- PED 0.14
- TPST N/A
- Revenue
- PED $35,334,000.00
- TPST N/A
- Revenue This Year
- PED N/A
- TPST N/A
- Revenue Next Year
- PED $17.41
- TPST N/A
- P/E Ratio
- PED $4.62
- TPST N/A
- Revenue Growth
- PED 3.93
- TPST N/A
- 52 Week Low
- PED $0.47
- TPST $5.35
- 52 Week High
- PED $1.00
- TPST $15.08
- Technical
- Relative Strength Index (RSI)
- PED 48.32
- TPST 49.76
- Support Level
- PED $0.58
- TPST $10.58
- Resistance Level
- PED $0.67
- TPST $11.13
- Average True Range (ATR)
- PED 0.04
- TPST 0.65
- MACD
- PED 0.01
- TPST -0.05
- Stochastic Oscillator
- PED 28.60
- TPST 20.22
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.